ArticleBMC palliative care2026
Charlson comorbidity index and palliative performance scale predict prognosis in dialysis patients: a retrospective cohort study.
Article in BMC palliative care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAccurate prognostication in end-stage kidney disease (ESKD) is essential for informed clinical decision-making, timely palliative care integration, and aligning treatments with patient goals. Commonly used tools include the Charlson Comorbidity Index (CCI) and the Palliative Performance Scale (PPS), although their comparative predictive performance in dialysis populations remains unclear. This study aimed to evaluate and compare the prognostic accuracy of the CCI, pre-dialysis PPS, and post-dialysis PPS in predicting natural mortality among patients with ESKD receiving renal replacement therapy (RRT).
methodsThis retrospective cohort study included 1,047 adult patients with ESKD who initiated hemodialysis or peritoneal dialysis at a tertiary hospital in southern Thailand between 2009 and 2022. The CCI was calculated based on diagnoses within 90 days prior to dialysis. PPS was assessed within 30 days before (pre-dialysis) and after (post-dialysis) initiation. The primary outcome was natural mortality. Predictive performance was evaluated using Kaplan–Meier survival analysis, multivariable Cox regression, and time-dependent receiver operating characteristic (ROC) curves at 30, 180, and 365 days.
resultsDuring a median follow-up of 5.89 years, 58.0% of patients died. The CCI effectively stratified long-term survival (median survival: 11.27 years for score < 6 vs. 3.80 years for > 8). However, for short-term prognosis, the post-dialysis PPS demonstrated superior discriminative ability. At 30 days, the continuous post-dialysis PPS model achieved a time-dependent AUC of 0.91 (95% CI 0.85–0.99), significantly outperforming the CCI (AUC 0.76). In multivariable analysis, age and post-dialysis PPS were associated with mortality. Functional recovery following dialysis initiation emerged as a critical marker of physiological resilience.
conclusionsThe CCI and PPS offer complementary prognostic value in ESKD. While the CCI reflects the accumulated burden of disease affecting long-term survival, the post-dialysis PPS captures dynamic physiological resilience and is a superior predictor of early mortality. Incorporating post-dialysis functional assessment into routine care may enhance risk stratification, identifying high-risk patients who would benefit from early palliative care integration and goals-of-care discussions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.